Formulary

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

Dalbavancin.(Selected literature)(Brief article)
May 01, 2008

Faropenem.(Selected literature)
May 01, 2008

Telavancin.(Selected literature)
May 01, 2008

Selected websites.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE-S...
May 01, 2008

Antibiotics.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE-STAGE D...
May 01, 2008

Ceftobiprole.(Approvable designation)(Brief article)
May 01, 2008

Sugammadex.(Recommended for approval)(Brief article)
May 01, 2008

Nplate.(Recommended for approval)(Nplate introduces Romiplostim)(Brief...
May 01, 2008

Gardasil.(Priority review)(Merck & Company Inc. introduces human papil...
May 01, 2008

First-time generic approvals.(FDA Drug Approvals)(Brief article)
May 01, 2008

Treanda: Bendamustine.(New molecular entity)(Drug overview)
May 01, 2008

Janumet.(FDA: actions in brief)(Brief article)
May 01, 2008

FDA approved labeling changes for peginterferon alfa-2b (PegIntron, Sc...
May 01, 2008

Xyzal.(FDA: actions in brief)(levocetirizine was approved for the trea...
May 01, 2008

Istradefylline: an adenosine receptor antagonist for the treatment of ...
May 01, 2008

Ceftobiprole.(Selected literature)
May 01, 2008

Amrubicin.(Orphan drug designation)(Amrubicin from Celgene Corp.)(Brie...
May 01, 2008

Liquadd.(FDA: actions in brief)(Brief article)
May 01, 2008

NovoLog.(FDA: actions in brief)(Brief article)
May 01, 2008

Current and emerging treatment options for postmenopausal osteoporosis...
May 01, 2008